Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome

Journal of Clinical Laboratory Analysis

Volumn 20, Issue 1, 2006, Pages 15-18

  Grypiotis, Panagiotis ^a,b   Ruffatti, Amelia ^a   Pengo, Vittorio ^a   Tonello, Marta ^a   Biasiolo, Alessandra ^a   Zamboni, Daniela ^a   Cavazzana, Anna ^a   Todesco, Silvano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Activated partial thromboplastin time; Antiphospholipid syndrome; Diluted Russell's viper venom time; Lupus anticoagulants; Silica clotting time; Thrombosis

Indexed keywords

LUPUS ANTICOAGULANT; VIPER VENOM;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LABORATORY DIAGNOSIS; MALE; PARTIAL THROMBOPLASTIN TIME; SENSITIVITY AND SPECIFICITY; SILICA CLOTTING TIME;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; BLOOD COAGULATION TESTS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SILICON DIOXIDE;

VIPERINAE;

EID: 33644784097     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20093     Document Type: Article

References (18)

1. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-1311.
2. Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002;126:1424-1429.
3. Jain A, Dash S, Marwaha N, Deodhar SD, Seghal S. Assays for lupus antigoagulant:the sensitivity of different assays. Med Lab Sci 1991;48:31-35.
4. Chantarangkul V, Tripodi A, Arbini A, Mannuci PM. Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants. Thromb Res 1992;67:355-365.
5. Norbis F, Barbui T, Galli M. Diluted Russell's viper venom time colloidal silica clotting time for the identification of the phospholipid-dependent inhibitors of coagulation. Thromb Res 1997;85:427-431.
6. Luddington R, Scales C, Baglin T. Lupus anticoagulant testing with optical end point automation. Thromb Res 1999;96:197-203.
7. Galli M, Finazzi G, Norbis F, Marziali S, Marchioli R, Barbui T. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile. Thromb Haemost 1999;81:695-700.
8. Galli M, Dlott J, Norbis F, et al. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests. Thromb Haemost 2000;84:1012-1016.
9. Dragoni F, Minotti C, Palumbo G, et al. As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant. Thromb Res 2001;101:45-51.
10. Tripodi A, Chantarangkul V, Clerici M, Mannucci PM. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Thromb Haemost 2002;88:583-586.
11. Triplett DA. Lupus anticoagulants: diagnostic dilemma and clinical challenge. Clin Lab Sci 1997;10:223-228.
12. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003;101:1827-1832.
13. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995;74:1185-1190.
14. Tincani A, Balestrieri G, Allegri F, et al. Overview on anticardiolipin ELISA standardization. J Autoimmunol 2000;15:195-197.
15. Arvieux J, Roussel B, Jacob MC, Colomb MG. Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as an antigen. J Immunol Methods 1991;143:223-229.
16. Tincani A, Allegri F, Balestrieri G, et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004;114:553-558.
17. 2-glycoprotein I antibodies-when and how should they be measured? Thromb Res 2004;114:527-531.
18. 2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood 2004;104:3598-3602.